$230.19
0.14% yesterday
NYSE, Jun 11, 10:10 pm CET
ISIN
US0905721082
Symbol
BIO
Sector

Bio-Rad Laboratories, Inc. Class B Stock price

$230.19
-26.49 10.32% 1M
-111.32 32.60% 6M
-98.32 29.93% YTD
-50.98 18.13% 1Y
-208.45 47.52% 5Y
+78.96 52.21% 10Y
+172.84 301.38% 20Y
NYSE, Closing price Wed, Jun 11 2025
-0.33 0.14%
ISIN
US0905721082
Symbol
BIO
Sector

Key metrics

Market capitalization $6.27b
Enterprise Value $5.81b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 17.51
EV/Sales (TTM) EV/Sales 2.29
P/S ratio (TTM) P/S ratio 2.47
P/B ratio (TTM) P/B ratio 0.97
Revenue growth (TTM) Revenue growth -2.46%
Revenue (TTM) Revenue $2.54b
EBIT (operating result TTM) EBIT $308.60m
Free Cash Flow (TTM) Free Cash Flow $332.00m
Cash position $1.66b
EPS (TTM) EPS $-77.28
P/S forward 2.49
EV/Sales forward 2.31
Short interest 6.29%
Show more

Is Bio-Rad Laboratories, Inc. Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,836 stocks worldwide.

Bio-Rad Laboratories, Inc. Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

Buy
67%
Hold
33%

Financial data from Bio-Rad Laboratories, Inc. Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,541 2,541
2% 2%
100%
- Direct Costs 1,178 1,178
3% 3%
46%
1,364 1,364
2% 2%
54%
- Selling and Administrative Expenses 794 794
3% 3%
31%
- Research and Development Expense 261 261
11% 11%
10%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 309 309
10% 10%
12%
Net Profit -2,164 -2,164
571% 571%
-85%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories, Inc. Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Rad Laboratories, Inc. Class B Stock News

Neutral
Business Wire
14 days ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Operating Officer Jon DiVincenzo will host one-on-one meetings with investors during the Jefferies Global Healthcare Conference in New York City, on June 4, 2025. About Bio-Rad Bio-Rad Laboratori...
Neutral
Business Wire
about one month ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May ...
Neutral
Seeking Alpha
about one month ago
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q1 2025 Earnings Conference Call May 1, 2025 5:30 PM ET Company Participants Edward Chung - Head of Investor Relations Jon DiVincenzo - President and Chief Operating Officer Roop Lakkaraju - Executive Vice President and Chief Financial Officer Norman Schwartz - Chief Executive Officer Conference Call Participants Patrick Donnelly - Citigroup Dan Leonard - ...
More Bio-Rad Laboratories, Inc. Class B News

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 7,700
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today